Clinical Trials Browser

Completed × Interventional × Advanced Solid Cancers × Clear all

NCT02694822 2025-03-17

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

Phase 1/2 Completed

89 enrolled 22 charts

Advanced Solid Cancers

NCT03956680 2025-02-19

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

Phase 1 Completed

Advanced Solid Cancers

NCT01019941 2010-12-16

126ASC08Q

Phase 1 Completed

Advanced Solid Cancers